In vivo glycemic regulation ability of the GRS glucagon MN patch to lower hypoglycemia risks was further assessed with a streptozotocin (STZ) ‐induced insulin‐deficient diabetic mouse model. This evidence concerns the gene GCG and Hypoglycemia.